ChainReactor Technologies provides infrastructure for industrial biology by combining physical AI, process engineering, and patented advanced manufacturing. The company offers modular benchtop bioreactors and a large biological model to help biomanufacturers predict cell behavior and test processes at scale before commercial production.
Subscribe to see ChainReactor Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ChainReactor Technologies, Inc. is a biotechnology company headquartered in Indianapolis, United States. Its most recent funding round raised $10,000 in October 2017.
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ChainReactor Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Petrichor Bio builds fabless wet labs designed specifically for frontier AI labs to address data constraints in biological research. The company provides specialized biological data and infrastructure to support advancements in AI-driven biology.
AbInitio Bio is an AI-native operating platform for drug development and manufacturing headquartered in San Francisco, California. Founded in 2026, the privately held company builds software featuring version history, review gates, and accountable approvals for biotech research.
Anaula builds autonomous bioreactors designed for pharmaceutical and biological production. The company integrates hardware, robotics, and software into a closed-loop system that senses, controls, and corrects manufacturing processes without human operator intervention.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Pow Bio is a biotechnology company developing continuous fermentation and bioprocessing technology for microbial production. It serves industrial biotechnology companies seeking to manufacture chemicals, materials, and other products more efficiently using engineered microorganisms.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ChainReactor Technologies, Inc.? Suggest a correction · Work at ChainReactor Technologies, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.